Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

How Many Chronic Myeloid Leukemia (CML) Patients in Chronic Phase (CP) Benefit from Treatment Free Remission? a Single Center Real-Life Experience

Mariella D'Adda, Valeria Cancelli, Sofia Terlizzi, Annamaria Pelizzari, Samantha Ferrari, Diego Bertoli, Chiara Bottelli, Nicola Bianchetti, Annalisa Peli, Ilaria Accarino, Carlotta Giupponi, Alessandra Tucci

Blood (2024) 144 (Supplement 1): 6612.

https://doi.org/10.1182/blood-2024-210714

Published: 2024

Journal Articles

Sustained Residual Disease Negativity Assessed By Diffusion-Weighted Whole-Body MRI (DW-MRI) Has Strong Predictive Relevance for Survival in Newly Diagnosed Multiple Myeloma Patients on Maintenance Therapy after Autologous Stem Cell Transplantation (ASCT)

Angelo Belotti, Rossella Ribolla, Alberta Villanacci, Marco Chiarini, Viviana Giustini, Giulia Vittoria Facchetti, Claudia Crippa, Valeria Cancelli, Samantha Ferrari, Annalisa Peli, Chiara Bottelli, Chiara Cattaneo, Chiara Saeli, Aldo M. Roccaro, Luigi Grazioli, Giuseppe Rossi, Alessandra Tucci

Blood (2021) 138 (Supplement 1): 1641.

https://doi.org/10.1182/blood-2021-147694

Published: 2021

Journal Articles

Longitudinal Serological Response to Sars-COV-2 in Patients Affected By Hematologic Diseases

Chiara Cattaneo, Valeria Cancelli, MD, Chiara Pagani, MD, Alessandra Tucci, MD, Giuseppe Rossi, MD, Luisa Imberti, MD, Alessandra Sottini, BS, Kerry Dobbs, BS, Elana Shaw, BS, Luigi D. Notarangelo, MD, Jeffrey Cohen, MD, Peter Burbelo, PhD

Blood (2020) 136 (Supplement 1): 4.

https://doi.org/10.1182/blood-2020-141355

Published: 2020

Journal Articles

External Validation of Diffusion Weighted Whole Body MRI (DW-MRI) Response Assessment Category (RAC) Criteria Proposed By the Myeloma Response Assessment and Diagnosis System (MY-RADS) Imaging Recommendations: Prognostic Role of Imaging Response after Transplant in Multiple Myeloma and Comparison with MRD Evaluation By Flow Cytometry

Angelo Belotti, Rossella Ribolla, MD, Valeria Cancelli, MD, Alberta Villanacci, Valentina Angelini, Samantha Ferrari, Annalisa Peli, MD, Chiara Cattaneo, MD, Marco Chiarini, MSc, Luigi Grazioli, MD, Giuseppe Rossi, MD, Alessandra Tucci, MD

Blood (2020) 136 (Supplement 1): 41–42.

https://doi.org/10.1182/blood-2020-135969

Published: 2020

Journal Articles

The IMWG Frailty Score and Age Can be More Effective Than Clinical Judgement in the Selection of Elderly Patients with Newly Diagnosed Multiple Myeloma Who Can Benefit from an Intensive Treatment Approach with High Dose Melphalan and Autologous Stem Cell Transplantation

Angelo Belotti, MD, Rossella Ribolla, Valeria Cancelli, MD, Nicola Bianchetti, Claudia Crippa, MD, Samantha Ferrari, MD, Chiara Bottelli, MD, Chiara Cattaneo, MD, Vincenza Orlando, PharmD, Marco Chiarini, Luigi Grazioli, MD, Giuseppe Rossi

Blood (2018) 132 (Supplement 1): 2151.

https://doi.org/10.1182/blood-2018-99-113022

Published: 2018

Journal Articles

Comparative Study on Fresenius-ATG Versus Thymoglobuline-ATG for the Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation from Matched Unrelated Donor: A Single Center Experience on 76 Patients

Nicola Polverelli, MD PhDstudent, Michele Malagola, MD PhD, Alessandro Turra, MD, Cristina Skert, MD, Federica Cattina, MD PhD, Benedetta Rambaldi, MD, Rossella Ribolla, MD, Valeria Cancelli, MD, Francesca Schieppati, MD, Marta Bonetti, MD, Simona Bernardi, PhD, Simone Perucca, PhD, Camilla Zanaglio, Domenico Russo, MD

Blood (2016) 128 (22): 4601.

https://doi.org/10.1182/blood.V128.22.4601.4601

Published: 2016

Journal Articles

Incidence and Outcome of Bacterial Blood Stream Infections in Allotransplanted Patients: Rethinking the Role of Fluoroquinolone Prophylaxis

Benedetta Rambaldi, MD, Michele Malagola, MD PhD, Giuseppe Ravizzola, MD, Giorgio Giannetta, Nicola Polverelli, MD PhDstudent, Cristina Skert, MD, Alessandro Turra, MD, Valeria Cancelli, MD, Federica Cattina, MD PhD, Francesca Schieppati, MD, Arnaldo Caruso, MD, Domenico Russo, MD

Blood (2016) 128 (22): 2223.

https://doi.org/10.1182/blood.V128.22.2223.2223

Published: 2016

Journal Articles

Assessment of BCR-ABL1 Transcript Levels By Digital PCR (dPCR) in CML Patients who Achieved a Deep Molecular Response (DMR: MR 4.0 , MR 4.5 And MR 5.0 ) with Tkis May Improve the Detection of Minimal Residual Disease (MRD) and the Selection of Patients for Treatment Free Remission (TFR)

Blood (2016) 128 (22): 3096.

https://doi.org/10.1182/blood.V128.22.3096.3096

Published: 2016

Journal Articles

A Gene Panel NGS-Based Strategy for Genomic Characterization of Acute Myeloid Leukemias (AMLs)

Simona Bernardi, Federica Cattina, Andrea Di Palma, Erika Borlenghi, MD, Francesca Schieppati, Simone Perucca, Valeria Cancelli, Alessandro Turra, Michele Malagola, Crisitina Skert, Carla Filì, Chiara Cattaneo, MD, Angela Passi, Mirko Farina, Giuseppe Rossi, MD, Flavio Mignone, Domenico Russo

Blood (2015) 126 (23): 4952.

https://doi.org/10.1182/blood.V126.23.4952.4952

Published: 2015

Journal Articles

Index of Bone Marrow Output and Imbalance of B-Lymphocyte Homeostasis before and after Transplantation Correlate Differently with Graft-Versus-Host Disease and Relapse

Crisitina Skert, Simone Perucca, Imberti Luisa, Chiarini Marco, Michele Malagola, Carla Filì, Viviana Giustini, MSC, Claudia Ghidini, BSC, Federica Cattina, Alessandro Turra, Valeria Cancelli, Simona Bernardi, Domenico Russo

Blood (2015) 126 (23): 3150.

https://doi.org/10.1182/blood.V126.23.3150.3150

Published: 2015

Journal Articles

Digital PCR (dPCR) Overcomes the Limitations in Detection and in Quantification of Quantitative PCR (qPCR) and Reveals Different Levels of BCR-ABL1 Copies/µl Among the Chronic Myeloid Leukemia (CML) Patients Achieving Major (MR 3.0 ) or DEEP (MR 4.0 , MR 4.5 and MR 5.0 ) Molecular Response with Tyrosin Kynase Inhibitors (TKIs)

Simona Bernardi, Andrea Di Palma, Mario Tiribelli, MD, Erika Codarin, Giuseppina Ruggeri, Maria Teresa Bochicchio, Michele Malagola, Federica Cattina, Simone Perucca, Valeria Cancelli, Crisitina Skert, Gianantonio Rosti, MD, Fausto Castagnetti, PhD, Luigi Caimi, Giuseppe Rossi, Giovanni Martinelli, Domenico Russo

Blood (2015) 126 (23): 4028.

https://doi.org/10.1182/blood.V126.23.4028.4028

Published: 2015

Journal Articles

Parameters of Protein Metabolism and Thyroid Function As Predictors in a Scoring System for Acute and Chronic Graft-Versus-Host Disease

Cristina Skert, MD, Alessandro Turra, Michele Malagola, Simone Perucca, Valeria Cancelli, Rosa Daffini, Rossella Ribolla, Cesare Bergonzi, Carla Filì, MD, Chiara Pagani, MD, Andrea Di Palma, Federica Cattina, MD PhD, Simona Bernardi, Domenico Russo, MD PhD

Blood (2014) 124 (21): 3932.

https://doi.org/10.1182/blood.V124.21.3932.3932

Published: 2014

Journal Articles

Patterns of Lymphocyte Subsets and Index of Bone Marrow Output (KRECs) Correlate Differently with Graft-Versus-Host Disease and Relapse

Cristina Skert, MD, Simone Perucca, Luisa Imberti, Marco Chiarini, MSc, Michele Malagola, Carla Filì, MD, Cesare Bergonzi, Rossella Ribolla, Valeria Cancelli, Alessandro Turra, Federica Cattina, MD PhD, Andrea Di Palma, Domenico Russo, MD PhD

Blood (2014) 124 (21): 3933.

https://doi.org/10.1182/blood.V124.21.3933.3933

Published: 2014

Journal Articles

WT1 Monitoring of Minimal Residual Disease (MRD) in Patients with Acute Myeloid Leukemia

Michele Malagola, Crisitina Skert, Enrico Morello, MD, Francesca Antoniazzi, MD, Erika Borlenghi, MD, Alessandro Turra, Chiara Pagani, MD, Rossella Ribolla, Valeria Cancelli, Federica Cattina, MD PhD, Elisa Alghisi, Simona Bernardi, Simone Perucca, Andrea Di Palma, Giuseppina Ruggeri, Giuseppe Rossi, Luigi Caimi, Domenico Russo, MD

Blood (2014) 124 (21): 3695.

https://doi.org/10.1182/blood.V124.21.3695.3695

Published: 2014

Journal Articles

Updating Long-Term Outcome of Intermittent Imatinib (INTERIM) Treatment in Elderly Patients with Ph+-CML

Domenico Russo, MD, Giovanni Martinelli, Michele Malagola, Valeria Cancelli, Cristina Skert, MD, Simona Soverini, PhD, Ilaria Iacobucci, PhD, Diamante Turri, Salvatore Mirto, MD, Marco Gobbi, MD, Ivana Pierri, MD, Umberto Vitolo, Patrizia Pregno, MD, Miriam Fogli, Nicoletta Testoni, Antonio De Vivo, Fausto Castagnetti, Enrica Morra, Ester Pungolino, MD, Francesco Di Raimondo, MD, Fabio Stagno, MD PhD, Giuliana Alimena, Massimo Breccia, MD, Francesco Nobile, Bruno Martino, Alessandro Rambaldi, Tamara Intermesoli, MD, Giuseppe Saglio, MD, Giovanna Rege Cambrin, Giuseppe Visani, MD, Giuseppina Nicolini, Paolo de Fabritiis, MD, Elisabetta Abruzzese, MD, Renato Fanin, MD, Mario Tiribelli, MD, Piero Galieni, MD, Catia Bigazzi, Giorgina Specchia, MD, Emanuele Angelucci, Emilio Usala, MD, Caterina Musolino, MD, Sabina Russo, Gianluca Gaidano, MD PhD, Monia Lunghi, MD, Francesco Lauria, MD, Monica Bocchia, MD, Francesco Rodeghiero, Anna D'Emilio, Alberto Bosi, MD, Valeria Santini, Giovanni Quarta, MD, Mariella Girasoli, Giuseppe Fioritoni, MD, Roberto Di Lorenzo, Bruno Mario Cesana, Gianantonio Rosti

Blood (2014) 124 (21): 1794.

https://doi.org/10.1182/blood.V124.21.1794.1794

Published: 2014

Journal Articles

Targeting HRASV12G Expression to the Zebrafish Early Hemogenic Progenitors Induces a Myeloproliferative Disorder by Repressing the Notch Pathway

Elisa Alghisi, Michele Malagola, Cristina Santoriello, Martin Distel, Christiaan Henkel, Cristina Skert, MD, Carla Filì, MD, Cesare Bergonzi, Simone Perucca, Alessandro Turra, Andrea Di Palma, Valeria Cancelli, Rossella Ribolla, Federica Cattina, Simona Zedda, Simona Bernardi, Domenico Russo, Marina Mione

Blood (2012) 120 (21): 4676.

https://doi.org/10.1182/blood.V120.21.4676.4676

Published: 2012

Journal Articles

Establishing a New Zebrafish Model to Study Malignant Transformation in Myeloproliferative Disorders

Elisa Alghisi, Michele Malagola, Cristina Santoriello, Cristina Skert, MD, Carla Filì, Cesare Bergonzi, Annalisa Peli, Alessandro Turra, Valeria Cancelli, Rossella Ribolla, Federica Cattina, MD, Marina Mione, Domenico Russo

Blood (2011) 118 (21): 4711.

https://doi.org/10.1182/blood.V118.21.4711.4711

Published: 2011

NARROW

How Many Chronic Myeloid Leukemia (CML) Patients in Chronic Phase (CP) Benefit from Treatment Free Remission? a Single Center Real-Life Experience

Sustained Residual Disease Negativity Assessed By Diffusion-Weighted Whole-Body MRI (DW-MRI) Has Strong Predictive Relevance for Survival in Newly Diagnosed Multiple Myeloma Patients on Maintenance Therapy after Autologous Stem Cell Transplantation (ASCT)

Longitudinal Serological Response to Sars-COV-2 in Patients Affected By Hematologic Diseases

The IMWG Frailty Score and Age Can be More Effective Than Clinical Judgement in the Selection of Elderly Patients with Newly Diagnosed Multiple Myeloma Who Can Benefit from an Intensive Treatment Approach with High Dose Melphalan and Autologous Stem Cell Transplantation

Comparative Study on Fresenius-ATG Versus Thymoglobuline-ATG for the Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Stem Cell Transplantation from Matched Unrelated Donor: A Single Center Experience on 76 Patients

Incidence and Outcome of Bacterial Blood Stream Infections in Allotransplanted Patients: Rethinking the Role of Fluoroquinolone Prophylaxis

Assessment of BCR-ABL1 Transcript Levels By Digital PCR (dPCR) in CML Patients who Achieved a Deep Molecular Response (DMR: MR 4.0 , MR 4.5 And MR 5.0 ) with Tkis May Improve the Detection of Minimal Residual Disease (MRD) and the Selection of Patients for Treatment Free Remission (TFR)

A Gene Panel NGS-Based Strategy for Genomic Characterization of Acute Myeloid Leukemias (AMLs)

Index of Bone Marrow Output and Imbalance of B-Lymphocyte Homeostasis before and after Transplantation Correlate Differently with Graft-Versus-Host Disease and Relapse

Parameters of Protein Metabolism and Thyroid Function As Predictors in a Scoring System for Acute and Chronic Graft-Versus-Host Disease

Patterns of Lymphocyte Subsets and Index of Bone Marrow Output (KRECs) Correlate Differently with Graft-Versus-Host Disease and Relapse

WT1 Monitoring of Minimal Residual Disease (MRD) in Patients with Acute Myeloid Leukemia

Updating Long-Term Outcome of Intermittent Imatinib (INTERIM) Treatment in Elderly Patients with Ph+-CML

Targeting HRASV12G Expression to the Zebrafish Early Hemogenic Progenitors Induces a Myeloproliferative Disorder by Repressing the Notch Pathway

Establishing a New Zebrafish Model to Study Malignant Transformation in Myeloproliferative Disorders

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only